Jessica N. Abraham | Designer. Writer. Publicist.

19+ Years of Expertise in Digital Marketing, Social Branding and Public Relations.

  • Home
  • Contact
  • About
  • Home
  • Contact
  • About

No Widgets found in the Sidebar Alt!

  • Biotricity provides remote cardiac monitoring to patients through its biokit and Bioflux services. Biotricity's medtech technologies can be found in Samsung Watch4 devices and as a standalone platform at your local physical or health services provider.
    Medtech,  Benzinga,  Biotechnology,  Business,  Finance,  Health,  IoT,  Technology,  Wearable Devices

    Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring

    September 15, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) is reforming the healthcare market as one of the fastest-growing companies in medtech. The company bridges the gap in remote cardiac monitoring, preventive and chronic care management by using the power of IoT (internet of things), wearables, and connected devices.  Not only does the company offer real-time, comprehensive monitoring and diagnostic services for cardiac-related healthcare and comorbidities, but its devices are also built with features that can dispatch emergency care services should any anomalies or arrhythmias occur when a device is worn. …

    read more
    Jessica N. Abraham Comments Off on Biotricity Continues to Transform the Way We Do Health: Medtech Launches New Biokit Solution, Aims at Personal Health Monitoring

    You May Also Like

    Top Tech Startups, Best Tech Startups, Denver Colorado

    BEST TECH STARTUPS IN DENVER, RANKED

    May 20, 2021
    Best startup accelerators, Top startup accelerators, Best accelerators, Top accelerators, Silicon Valley,

    BEST ACCELERATORS IN SILICON VALLEY, RANKED

    July 15, 2021
    Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,

    Biotricity Reports Q1 Earnings at 290% for FY2022

    September 2, 2021
  • Medtech Cardiac Monitoring Device, Wearable, Biotricity, Bioflux, Samsung, Watch4,
    Business,  Benzinga,  Finance,  Health,  IoT,  Medtech,  Technology,  Wearable Devices

    Biotricity Reports Q1 Earnings at 290% for FY2022

    September 2, 2021 /

    Previously Published to Benzinga: The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Biotricity (NASDAQ: BTCY) has been taking the world of medtech by storm, introducing primary care providers across the country to its remote heart monitoring devices. Always connected, these wearable devices have been giving power back to those suffering from chronic cardiac conditions and simultaneous comorbidities — the simultaneous presence of two or more diseases or medical conditions and often relative of one another.  Through remote heart monitoring and diagnostic technologies, doctors can screen their patients from a distance, even alerted to a possible emergency if the…

    read more
    Jessica N. Abraham Comments Off on Biotricity Reports Q1 Earnings at 290% for FY2022

    You May Also Like

    Jessica Abraham, Jessica N Abraham, Benzinga, Technology, Business, Tech, Tech News, Technology News, Business News, Finance News, Invest, Investing, Education, Brands, Cannabis,

    Follow Jessica N. Abraham on Benzinga

    August 3, 2021
    Healthcare Technology , Electronic Records, Healthcare Innovation, Medical Devices, Mobile & Connected Health, Home Health Monitorning, Health Information Exchange (HIE), telemedicine, Electronic Medical Records, Mobile Health Care, connected health, e-health, Point of Care, Medical Device Integration, Telemedicine, Medical Image Management, glucose monitor, remote clinical care, smart pills, iPad healthcare, Proteus, medical sensors, biosensors, mobile health sensors, smart health, home health monitoring, vital sign monitoring, medical text to speech, capsule endoscopy, medication management, medical smart cards, patient bar coding, EHR, EMR, PHR, clinical decision support, health information exchange, clinical documentation, Microsoft HealthVault, Google Health

    Evariant Awarded Funding to Innovate Healthcare CRM

    December 7, 2015
    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    What is ImQuest, and How is Statera Biopharma using it to Develop New Immune Therapies for Cancer, Infectious Disease and Autoimmune Disorders?

    September 8, 2021
  • Business
  • Technology
  • Career Development
  • Education
  • Entertainment
  • Fashion
  • Relationships
  • Tips
  • Travel
Ashe Theme by WP Royal.